Patents Represented by Attorney Goodwin Procter LLP
  • Patent number: 8193186
    Abstract: The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations.
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: June 5, 2012
    Assignee: AEterna Zentaris GmbH
    Inventors: Irene Seipelt, Ulf R. Rapp, Ludmilla Wixler, Eckhard Claus, Eckhard Günther
  • Patent number: 8191420
    Abstract: A new high G-range damped acceleration sensor is proposed with a proof mass optimized for maximized, bi-directional and symmetrical damping to accommodate acceleration ranges above and beyond several thousand G's. In order to achieve the maximum, bi-directional and symmetrical damping, the high G-range acceleration sensor is designed to have minimum amount of mass in the proof mass while maximizing its surface areas. Such high G-range damped acceleration sensor can be applied to any application in which damping (or suppression of ringing) is desired at quite high frequencies.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: June 5, 2012
    Assignee: Meggitt (San Juan Capistrano), Inc.
    Inventors: Leslie Bruce Wilner, Tom Kwa
  • Patent number: 8195329
    Abstract: The present invention provides a random access and random load dispensing unit including a housing, at least one support located in the housing and defining a first axis, a plurality of platforms movable along the support along the first axis, a plurality of bins supported on the platforms, the bins being movable with the platforms, and a shuttle assembly movable along the first axis and further movable along a second axis substantially perpendicular to the first axis between the plurality of platforms to access and retrieve products stored in the bins.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: June 5, 2012
    Assignee: Asteres, Inc.
    Inventors: Linda J. Pinney, John A. Beane, Angus R. Colson, Jr., David R. Williams, Keith Kopitzke, Keith W. Reynolds, Erik Howard Barnes
  • Patent number: 8193243
    Abstract: Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, using substantially continuous administration of carbidopa or salt thereof together with administration of levodopa.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: June 5, 2012
    Assignee: Neuroderm, Ltd.
    Inventors: Oron Yacoby-Zeevi, Mara Nemas
  • Patent number: 8190521
    Abstract: Embodiments of the invention include a method and system for effectuating an electronic payment between a payor and a payee using an Electronic Funds Transfer (EFT) network. The method is implemented by a system having multiple processors. The payor may hold a payor account at a payor institution and the payee may have a payee account at a payee institution. The method includes generating a payment authorization identifying the payee institution, the payee account, and an amount of the payment and transmitting the payment authorization to the payor institution. The method further includes debiting the payor account by the amount of the payment; transmitting from the payor institution to the payee institution through the EFT network an EFT credit message representing a credit in the amount of the payment; and crediting the payee account in the amount of the payment in response to the receipt of the EFT credit message.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: May 29, 2012
    Assignee: JPMorgan Chase Bank, N.A.
    Inventors: Denis O'Leary, Vincent D'Agostino, S. Richard Re, Jessica Burney, Adam Hoffman
  • Patent number: 8187601
    Abstract: Monoclonal antibodies that bind and inhibit activation of fibroblast growth factor receptor 3 (FGFR3) are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of FGFR3.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: May 29, 2012
    Assignee: AVEO Pharmaceuticals, Inc.
    Inventors: Zhigang Weng, William M. Winston, Jr., Lyne Breault, Kristan Meetze, Solly Weiler, Jeno Gyuris
  • Patent number: 8187687
    Abstract: A spoolable pipe is disclosed, the spoolable pipe having an internal pressure barrier formed about a longitudinal axis, and a reinforcing layer(s) enclosing the internal pressure barrier that includes a solid hydrocarbon matrix. The pipe can also include an energy conductor(s) integrated with and/or located between the internal pressure barrier and/or the reinforcing layer(s).
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: May 29, 2012
    Assignee: Fiberspar Corporation
    Inventors: Thomas W. Wideman, Peter A. Quigley
  • Patent number: 8187902
    Abstract: A sensor includes a proof mass suspended by a suspension beam, the suspension beam having a thickness less than a thickness of the proof mass.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: May 29, 2012
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Marc S. Weinberg, Mirela G. Bancu, James A. Bickford, Jonathan J. Bernstein, Richard Elliott
  • Patent number: 8191091
    Abstract: A unified system of programming communication. The system encompasses the prior art (television, radio, broadcast hardcopy, computer communications, etc.) and new user specific mass media. Within the unified system, parallel processing computer systems, each having an input (e.g., 77) controlling a plurality of computers (e.g., 205), generate and output user information at receiver stations. Under broadcast control, local computers (73, 205), combine user information selectively into prior art communications to exhibit personalized mass media programming at video monitors (202), speakers (263), printers (221), etc. At intermediate transmission stations (e.g., cable television stations), signals in network broadcasts and from local inputs (74, 77, 97, 98) cause control processors (71) and computers (73) to selectively automate connection and operation of receivers (53), recorder/players (76), computers (73), generators (82), strippers (81), etc.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 29, 2012
    Assignee: Personalized Media Communications, LLC
    Inventors: John Christopher Harvey, James William Cuddihy
  • Patent number: 8190291
    Abstract: The present invention provides for devices and methods for vending regulated products, particularly controlled substances, including those containing pseudoephedrine. The present invention allows for the identification of consumers through reliable log-in-procedures, allows the consumer to select items, validates whether the purchase request complies with regulations, to facilitate the delivery of the requested product to a consumer. Other embodiments include a vending machine that is placed into a retail environment in which software enforces validation of the purchasers' identities, limits the amount of pseudoephedrine for each purchaser within the regulations of local, state and federal agencies.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: May 29, 2012
    Assignee: Asteres, Inc.
    Inventors: John A. Beane, Linda J. Pinney
  • Patent number: 8188416
    Abstract: In various embodiments, microengineered phantoms with microvascular networks serve as calibration standards for perfusion imaging systems.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: May 29, 2012
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Jeffrey T. Borenstein, Homer Pien, Mannudeep Kalra
  • Patent number: 8189738
    Abstract: Radiation beam parameters are determined by manipulating a tool about a patient in order to determine a desired beam entry point and/or beam angle. In certain embodiments, a visual representation of the beam may be displayed along with images of internal and external anatomical features of the patient, and used to determine couch and/or gantry manipulation parameters to move the patient into a desired position with respect to a treatment delivery device.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: May 29, 2012
    Assignee: Elekta Ltd.
    Inventors: Chantal Dussault, Martin Lachaine, Daniel Lodu, Martin Bonneville
  • Patent number: 8189875
    Abstract: Images of items of jewelry having gemstones embedded therein are imaged and analyzed to determine the weights associated with the gemstones and, separately the precious metal in which the gemstones are encased without having to remove the gemstones from the jewelry.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: May 29, 2012
    Assignee: TJS DMCC
    Inventor: Gabriel G. Nasser
  • Patent number: 8181531
    Abstract: A sensor may include a substrate that has a cavity formed in a surface thereof. A diaphragm, having a conductive portion, may be suspended over the cavity, a selective coating may be present on a face of the diaphragm outside of the cavity, and a counterelectrode may be spaced from and in opposition to the diaphragm. The diaphragm may deform upon interaction of the selective coating with an analyte and thereby alter a capacitance of the sensor in a manner indicative of a degree of interaction.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: May 22, 2012
    Inventors: Edwin Carlen, Marc S. Weinberg, Angela Z. Uhland, Jonathan Bernstein, John Aceti, Malinda M. Tupper
  • Patent number: 8184300
    Abstract: The penetration depth of surface acoustic wave scales with wavelength. To measure thinner films using impulse stimulated thermal scattering (ISTS) it is advantageous to reduce the measurement wavelength to on the order of 1 micron. One way to reduce the measurement wavelength is to employ a high numerical aperture lens to converge an excitation and probe laser beam in an optical system at wider angles. While doing this, the increased optical/mechanical tolerances can be reduced by fine-tuning the phase between an excitation laser pattern and a probe laser pattern by adjusting either a neutral-density filter or matching plate for a particular wavelength. Blocking unwanted diffraction order beams generated by the optical system with a specialized design beam block plate is needed to retain the long wavelength capability.
    Type: Grant
    Filed: December 8, 2005
    Date of Patent: May 22, 2012
    Inventor: Alexander Mazurenko
  • Patent number: 8183178
    Abstract: The present invention provides methods and compositions for performing multi-step nucleic acid mediated synthesis of a highly diverse collection of molecules, for example, small molecules and polymers. In the method, in at least two steps, multiple reaction intermediates and/or products are produced in the same step by different chemical reactions.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: May 22, 2012
    Assignee: President and Fellows of Harvard College
    Inventors: David R. Liu, Christopher T. Calderone
  • Patent number: 8184293
    Abstract: The invention relates to methods and systems for measuring and/or monitoring the chemical composition of a sample (e.g., a process stream), and/or detecting specific substances or compounds in a sample, using light spectroscopy such as absorption, emission and fluorescence spectroscopy. In certain embodiments, the invention relates to spectrometers with rotating narrow-band interference optical filter(s) to measure light intensity as a function of wavelength. More specifically, in certain embodiments, the invention relates to a spectrometer system with a rotatable filter assembly with a position detector rigidly attached thereto, and, in certain embodiments, the further use of various oversampling methods and techniques described herein, made particularly useful in conjunction with the rotatable filter assembly.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: May 22, 2012
    Assignee: Pason Systems Corp.
    Inventors: David Bonyuet, Vidi A. Saptari
  • Patent number: 8185877
    Abstract: A system and method for testing at least one application is provided. The system comprises a test plan or script creation module for enabling a user to create at least one test plan or script for use in testing the at least one application. The system also comprises a test results module for initiating and determining test results associated with testing of the at least one application according to the at least one test plan or script. In some embodiments, the test results module determines: (1) baseline test results achieved by resolving the at least one test plan or script against the at least one application prior to the application being put to actual use, and (2) dynamic test results achieved by resolving the at least one test plan or script against the at least one application after the at least one application has been put to actual use. The system may also include a comparison module for comparing the dynamic test results with the baseline test results.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: May 22, 2012
    Assignee: JPMorgan Chase Bank, N.A.
    Inventor: Brian Colcord
  • Patent number: 8175526
    Abstract: A magnetic flux coupling transducer system comprising a primary coil (51) and primary coupling core (52) and a secondary coil (54) and secondary coupling core (55) for passing communications signals and/or electrical power from one side of an electrically conductive barrier to receiving equipment on the other side.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: May 8, 2012
    Assignee: WFS Technologies Ltd.
    Inventors: Mark Rhodes, Brendan Hyland
  • Patent number: 8173646
    Abstract: Compounds of the Formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: May 8, 2012
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. Dewolf, Jr., Dalia R. Jakas